Active, not recruitingPHASE2, PHASE3NCT03797157

Human Milk Fortification in Extremely Preterm Infants

Studying Necrotizing enterocolitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Thomas Abrahamsson, MD, PhD
Principal Investigator
Thomas R Abrahamsson, MD, PhD
Region Östergötland
Intervention
H2MF(dietary_supplement)
Enrollment
229 enrolled
Eligibility
All sexes
Timeline
20192029

Study locations (5)

Collaborators

Sahlgrenska University Hospital · Region of Uppsala · Vasterbottens lans landsting · Prolacta Bioscience · Region Stockholm

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03797157 on ClinicalTrials.gov

Other trials for Necrotizing enterocolitis

Additional recruiting or active studies for the same condition.

See all trials for Necrotizing enterocolitis

← Back to all trials